CRMD – cormedix inc. (US:NASDAQ)
Stock Stats
News
Is It Too Late to Consider CorMedix After DefenCath Progress and Strong Price Gains? [Yahoo! Finance]
CorMedix (NASDAQ:CRMD) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.
CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath
5 High Earnings Yield Value Picks Ahead of Key Economic Reports [Yahoo! Finance]
Assessing CorMedix (CRMD): Is the Current Share Price Reflecting Its True Value? [Yahoo! Finance]
Form 4 CorMedix Inc. For: Dec 18 Filed by: Todisco Joseph
Form 144 CorMedix Inc. Filed by: Todisco Joseph
Form 4 CorMedix Inc. For: Dec 09 Filed by: Dillione Janet
Form 4 CorMedix Inc. For: Dec 09 Filed by: Lefkowitz Steven W
Form 144 CorMedix Inc. Filed by: Dillione Janet
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.